🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. Pegunigalsidase alfa

    Protalix BioTherapeutics

    Fabry Disease

    phase 3 mab completed

    1 trial

  2. Pembrolizumab 25 MG/ML [Keytruda]

    United Therapeutics Europe Ltd

    Lung Cancer, Nonsmall Cell

    phase 3 small molecule active

    1 trial

  3. Pentoxifylline

    United Therapeutics Europe Ltd

    Kidney Failure, Chronic

    phase 3 small molecule completed

    1 trial

  4. Peramivir

    Biocryst

    Influenza

    phase 3 small molecule completed

    5 trials

  5. Peramivir

    Biocryst

    Seasonal Influenza

    phase 3 small molecule completed

    1 trial

  6. Peramivir 150mg

    Biocryst

    Influenza

    phase 3 small molecule terminated

    1 trial

  7. Peramivir+SOC

    Biocryst

    Cough

    phase 3 small molecule terminated

    1 trial

  8. Phase III Randomized, Open-Label, Multicenter Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination with Lenalidomide in Comparison to Rituximab in Combination with Lenalidomide with a Non-Randomized, Single Arm US Extension of Mosunetuzumab in Combination with Lenalidomide in Patients with Follicular Lymphoma After at Least One Line of Systemic Therapy

    Hoffmann-La Roche

    Relapsed/refractory follicular lymphoma

    phase 3 other active

    1 trial

  9. Phlebotomy

    Atrium Therapeutics

    Hemochromatosis

    phase 3 other completed

    1 trial

  10. Phlebotomy and erythrocytapheresis

    Atrium Therapeutics

    Hereditary Hemochromatosis

    phase 3 other active

    1 trial

  11. Physiotherapy

    United Therapeutics Europe Ltd

    Sciatica

    phase 3 other completed

    1 trial

  12. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Neuropsychiatric Symptoms Related to Neurodegenerative Disease

    phase 3 small molecule completed

    2 trials

  13. Pioglitazone

    Takeda

    Impaired Glucose Tolerance

    phase 3 small molecule completed

    1 trial

  14. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Adult Attention Deficit Hyperactivity Disorder

    phase 3 small molecule completed

    1 trial

  15. Placebo

    Pfizer

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  16. Placebo

    Tobira Therapeutics

    Nonalcoholic Steatohepatitis

    phase 3 small molecule terminated

    1 trial

  17. Placebo

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    1 trial

  18. Placebo

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 3 small molecule active

    1 trial

  19. Placebo

    AbbVie

    Ulcerative Colitis (UC)

    phase 3 small molecule completed

    2 trials

  20. Placebo

    Ark Therapeutics

    Hyperphagia

    phase 3 small molecule on hold

    1 trial

  21. Placebo

    Protagonist Therapeutics, Inc

    Polycythemia Vera

    phase 3 small molecule active

    1 trial

  22. Placebo

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Ductal Carcinoma

    phase 3 small molecule terminated

    1 trial

  23. Placebo

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    2 trials

  24. Placebo

    Mineralys Therapeutics

    Hypertension

    phase 3 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources